generalripper Posted - 2 days ago

$CADL $janx valued at $2.4b off P1 prostate data

electic Posted - 2 days ago

what's worse than $GME? $JANX lol.

electic Posted - 3 days ago

the only stock more degen than $GME is $JANX

growthstock2120 Posted - 4 days ago

$JANX back to 62 boyd???

AdamFeurnstein Posted - 4 days ago

$JANX Platform tech worth $350M per Cantor, Possibly higher efficacy with dose escalation. Goldilocks in both efficacy and toxicity. March raise at $46.49. JNJ paid $2B for Ambrax ,105% premium for ADC. Current valuation mostly from 007, but vast other market opportunity with the platform.

AdamFeurnstein Posted - 4 days ago

$JANX

intratio Posted - 4 days ago

Janux Therapeutics, Inc. The engine has predicted this company s stock price will plummet in in the coming week and will have a very negative trend in the upcoming months $JANX

Theflash88 Posted - 5 days ago

$JANX Added more today.. waiting on Merck!

intratio Posted - 5 days ago

$JANX The mathematical model estimates this company s stock price has a clear poor short-term setup and has really poor long-term fundamentals

Thestocktraderhubzee Posted - 6 days ago

$JANX HC Wainwright & Co. Maintains Buy on Janux Therapeutics, Raises Price Target to $63

TupacLive Posted - 1 week ago

@MizCo @intratio this said the same thing about $JANX and cost me 1000’s

intratio Posted - 1 week ago

$JANX Janux Therapeutics, Inc. Our artificial intelligence is predicting this stock s value has a clear poor short-term setup with a very negative long-term outlook

biochirp Posted - 1 week ago

$JANX 42-44 would be nice entry

JGNYC Posted - 1 week ago

$JANX juicy dips coming I want $40 entry

LabPsycho Posted - 1 week ago

$SNSE $JANX @BiotechValues Awesome set of posts and explanations and I greatly appreciate the graphics and highlighing for extra clarity. Separately, I am not sure I fully understand backfilling? Going back and giving previously treated lower dose patients a higher dose?

BiotechValues Posted - 1 week ago

$SNSE - $CTMX and $JANX started to backfill because of efficacy

yus37 Posted - 1 week ago

$CTMX $XBI Why does the treatment work well for pancreatic cancer but not for other cancers? Could adjusting the dosage improve its effectiveness across different cancer types? Considering the promising data in pancreatic cancer , should they prioritize refining it for that while also exploring dosage adjustments for other cancers? Additionally, are patient backgrounds consistent across trials, considering factors like previous treatments, cancer stages, and ages? How does it compare to $JANX and others? As I continue my DD, I welcome thoughts from longs on this matter.

intratio Posted - 1 week ago

https://www.intratio.com/stock-forecast/JANX Our analyst is predicting that the stock price of this company will instantly and significantly lessen with a clear pessimistic long-term perspective $JANX

RepugNant Posted - 1 week ago

$CTMX $JANX You mean $JAGX right? ;)

Theflash88 Posted - 1 week ago

$CTMX $JANX Lol

Theflash88 Posted - 1 week ago

$JANX They want your shares!

JGNYC Posted - 1 week ago

$JANX want to start a position here

biochirp Posted - 1 week ago

$JANX low 40s would be nice to get in

RainbowTrump Posted - 1 week ago

$JANX recent events have convinced me to stay away from this

LabPsycho Posted - 1 week ago

$CNTX Lets do some comparisons - $VTYX recently raised $100 Million around $9/sh and they have phase 1/2 and already hundreds of millions of $$ $JANX is going to raise $150 million around $55/share That $CNTX is able to raise $100Million on an IND suggests to me the private investors are seeing what I saw last year in Anti-Claudin 6 antibody potential and reported on it here and detailed in this Youtube video. https://www.youtube.com/watch?v=5E7n2RQL1-4&t=316s

RockitMann Posted - 1 week ago

$JANX Does this mean the company sale is off? Asking for a friend.

BioLux Posted - 1 week ago

@RainbowTrump @F15EAGLE1 if you think the PSMA results for $JANX make it worth $3bn+ you should probably have a good hard look at the $CTMX results in pancreatic with EGFRxCD3 It’s not an either/or scenario at all IMO; both companies have incrementally validated the masking approach and we will see increasing BP interest in the field

BuyingSheep Posted - 1 week ago

@BioMan122 I think $CTMX data not bad but far from $JANX. Worst is management tried to ride the hype consciously knowing data not at par. Warned everybody on this board. Next will be a big capital increase after May 15 @ $4. All WHO bought tonight will be eternal bag holders IMHO.

Electic14 Posted - 1 week ago

@tiernster buy more $JANX. We need more bagholders. 🤡

Mcoomx01 Posted - 1 week ago

@Little_thebodyguard @BuyingSheep $JANX here we come